43 participants
Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-20
- Start Date:
- 2023-03-15
- Completion:
- 2026-03-19
Conditions
- Hepatocellular Carcinoma
Interventions
- DRUG
No Results Yet